Micrologix biotech Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Micrologix biotech

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Larry G. who wrote (588)	10/1/1999 8:48:00 AM
From: Carter Berezay	Read Replies (1) of 792

Larry G., it was a good deal for everyone. The "bought deal" went to investment firms in the business of making money for their clients. I would assume their investment dollar investment comprises a "small" amount of their investment capital pool. An investment in MBI will not make them rich! But it may (and it looks that way) give them an advantage over their competitors. These guys live and die by the percentage gain they deliver to their clients each year. Buying MBI (an unknown upstart biotech company) was a big deal for these guys. It looks right now that they made one heck of a deal for themselves. Never fault another investor for making some money! It was a major chance taken by these guys. MBI did get the money it needed to move MBI 226 into Phase II/III and two or three new indications into Phase I, all within the next 6 - 12 months. Tell me that WAS a bad deal for MBI? If MBI had sent you a letter saying send us a few thousand dollars (on our word) and we'll let you in on our deal, would you have? Good luck to all. Carter B.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next